OIG - McKnight's Long Term Care News

OIG

Clinical briefs for Thursday, June 17

Chatbots for dementia still in their infancy, tech researchers find … What to know about new Alzheimer’s drug Aduhelm, from scientist who led the trials … Advocacy group urges OIG to investigate FDA’s approval of new Alzheimer’s drug … First patient receives controversial Biogen Alzheimer’s drug at hospital … LTC care needs will double by 2065 … FDA approves Novartis’ drug for aggressive prostate cancer following positive trial results

The coming crackdown: COVID-19 and beyond

For more than a year, America’s nursing homes have been besieged by the COVID-19 pandemic, which has tragically claimed the lives of more than 130,000 residents and 1,600 staff. While America’s nursing homes are no outlier compared to nursing homes globally, the pandemic has nevertheless reignited debate about the American elder care system and regulators’…

Next post in News